Category: Technology

Category: Technology

Technology Partners

Kytopen FlowFect™ Platform to Be Used in GMP-Manufacture of an Engineered Cell Therapy – IND Submission and Clinical Study in 2024

Kytopen announces the first implementation of its GMP compliant Flowfect Tx™ cellular engineering...
Kytopen
July 16, 2024
Technology Partners

Kytopen Announces Collaboration with leading bioengineer Omid Veiseh, PhD. to Fuel Genome Engineering Research and Accelerate Cell Therapy Discovery

CAMBRIDGE, Mass. — July 11, 2023 — Kytopen, a leading biotechnology company specializing in...
Kytopen
July 11, 2023
Technology Partners

BioCentriq and Kytopen Expand Partnership to Expedite Impact of Transformative Gene-Editing Technology on Cell Therapy Manufacturing

Read the original release at BioCentriq.com NEWARK, NJ, June 6, 2023 – BioCentriq®, a strategic...
Kytopen
June 06, 2023
Technology Publications

Kytopen Reveals Automated High-Throughput Gene Editing Platform to Accelerate Cell Therapy Discovery, Development, and Manufacturing

Kytopen Reveals Automated High-Throughput Gene Editing Platform to Accelerate Cell Therapy...
Kytopen
May 24, 2023
Technology Team

MIT News: 3 Questions: Cullen Buie on a new era for cell therapies

Read the original post on MIT News
Kytopen
February 07, 2023
Technology Partners

Kytopen and Mirus Bio Announce Partnership to Unlock New and Scalable Genome Engineering Capabilities for the Next-Generation of Living Medicines

The two companies will collaborate to combine industry-leading technologies and tackle the...
Kytopen
February 07, 2023
Technology

Kytopen awarded NIH grant of up to $2M to unlock the power of engineered Natural Killer (NK) cells via Flowfect® platform

NIH/NIAID SBIR Fast Track grant accelerates the company’s commercial activities towards a non-viral...
Kytopen
June 15, 2021